Yuting Qiu
6 Papers
Yuting Qiu is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 5 publications.
Chat about Author
Papers
Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development
Haobo Li,Zhu Zhang,Yuting Qiu,Haoyi Weng,Shuai Yuan,Linfeng Xi,Feiya Xu,Xiaofan Ji,Risheng Hao,Pei-Ran Yang,Gang Chen,Xianbo Zuo,Zhenguo Zhai,Chen Wang +13 more
TL;DR: Using multidimensional data, this study suggests PLEK, SERPINA1, and SERPINE2 as compelling proteins that may provide key hints for future research and possible diagnostic and therapeutic targets for VTE.
24
Multi-copper oxidases SKU5 and SKS1 coordinate cell wall formation using apoplastic redox-based reactions in roots
Chaofan Chen,Yi Zhang,Jianfa Cai,Yuting Qiu,Chengxu Gao,Yi-Qun Gao,Meiyu Ke,Jiaomei Chen,Tongda Xu,Jiří Friml,Junqi Wang,Ruixi Li,Daiyin Chao,Baocai Zhang,Xu Chen,Zhen Gao +15 more
TL;DR: In this article , the role of the Arabidopsis (Arabidopsis thaliana) multicopper oxidase-like protein skewed 5 (SKU5) and its homolog SKU5-similar 1 (SKS1) in root cell wall formation through modulating ROS homeostasis was demonstrated.
Association between CES1 rs2244613 and the pharmacokinetics and safety of dabigatran: Meta-analysis and quantitative trait loci analysis
Haobo Li,Zhu Zhang,Haoyi Weng,Yuting Qiu,Pablo Zubiaur,Yu Zhang,Guohui Fan,Peiran Yang,Anna-Leena Vuorinen,Xianbo Zuo,Zhenguo Zhai,Chen Wang +11 more
TL;DR: A meta-analysis indicated a definite relation between the CES1 rs2244613 genotype and tolerability variations or pharmacokinetic fluctuations and the carriers of T allele showed higher dabigatran concentrations; therefore, they would benefit from a dose reduction.
8
Preclinical characterization of a novel anti-CD39/TGFβ-trap bispecific antibody that aims to modulate tumor microenvironment.
Hongtao Lu,Dawei Sun,Yehua Zhu,Jun Sun,Zhouwenli Meng,Quan Qiu,Yuting Qiu,Yanan Geng,R. Gao,Yu Huai Ho,Hongping Zhou,Zheng Song,Xiaoli Guo,Yefeng Lu,Liliang Xia,Shun Lu +15 more
TL;DR: In this paper , a bispecific antibody-ligand trap called ES014 was designed to simultaneously disable CD39 to prevent extracellular ATP from degradation and neutralize autocrine/paracrine TGFβ in the vicinity of target cells.
1062 ES009, a LILRB2-specific blocking antibody, reprograms myeloid cells into pro-inflammation phenotype and potentiates T cell activation
Xiaofeng Niu,Chunnian Wang,Jinfeng Zhao,Jiahui Hu,Yanfen Hu,Jun Sun,Xiaoyan Zheng,Yuting Qiu,Zhihao Wu,Yangsheng Qiu,Quan Qiu,Hongtao Lu +11 more
- 01 Nov 2022
TL;DR: In this paper , an anti-LILRB2 mAb called ES009 has been developed to reprograms myeloid cells into a pro-inflammation phenotype and potentiates T cell activation.